MULTILAYERED POLYELECTROLYTE FILMS CONTAINING IMMOBILIZED GOLD NANOPARTICLES. Pallotta Arnaud

Similar documents
ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

FABRICATION OF POLYMERIC FILMS AND COATINGS ON NICKEL-TITANIUM SHAPE MEMORY ALLOY AND THEIR BIOMEDICAL APPLICATIONS

Coronary heart disease. S. Sundar Manoharan, Department of Chemistry Indian Inst of Technology Kanpur

Invited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases

Catch-up Phenomenon: Insights from Pathology

Supporting Information for. Uptake of poly(2-hydroxypropylmethacrylamide)-coated gold nanoparticles

The titanium nitride oxide stent an alternative to DES. Adam de Belder MD FRCP Sussex Cardiac Centre BSUH on behalf of Hexacath

Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18

Pathology of Cardiovascular Interventions. Body and Disease 2011

Glycocalyx Degradation in Retinal and Choroidal Capillary Endothelium in Rats with Diabetes and Hypertension

Surface-Enhanced Raman Scattering Active Gold Nanoparticles. with Enzyme-Mimicking Activities for Measuring Glucose and

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

In-stent Restenosis: the Achille's Heel of SFA Stenting

Summit TCT Asia Pacific

L-PRF Leukocyte-Platelet Rich Fibrin

Hemocompatibility of Stents

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Polyphenol-eluting stent reduces restenosis and promotes vascular healing in a rat model of arterial angioplasty and stenting

Novel Concept Regenerative, Immune-Privileged, Bio-Stentgraft

THROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan

BIOMATERIALS. What is a Biomaterial? Attention! Info on Term Projects. Anything in contact with human body?

A Highly Flexible Slotted Tube Stent Design Coated with a-sic:h First Clinical Experiences

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Smooth muscle pharmacology & interventional cardiology

Second Generation Drug Eluting Stents: From Inhibition to Healing

Development Of DES Technology. HUO Yong,MD FACC Peking University First Hospital President-elect Chinese Society of Cardiology

Smooth muscle pharmacology & interventional cardiology

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

Supplemental Figure 1. Quantification of proliferation in thyroid of WT, Ctns -/- and grafted

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

8 th June 2015, Valencia, Spain. INNOVHUB-SSI, Paper Division, Milano, Italy

Copyright 2010 Pearson Education, Inc. Blood Vessel Structure

Imagerie Cellulaire. O Clément. Laboratoire de Recherche en Imagerie, Inserm U 970. F Gazeau, C Wilhelm

Durable outcomes. Proven performance.

Pathology of Coronary Artery Disease

III. Results and Discussion

Glutathione Peroxidase Assay Kit

Chemical Surface Transformation 1

List of Figure. Figure 1.1. Selective pathways for the metabolism of arachidonic acid

Boston Scientific Corporation Drug-Eluting Stent Program

as a Mechanism of Stent Failure

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE

Histopathology: chronic inflammation

TTP, Sickle Cell Disease, and the role of von Willebrand factor

FLUID MECHANICAL PERTURBATIONS INDUCED BY STENT IMPLANTATION: A NUMERICAL STUDY

How to detect early atherosclerosis ; focusing on techniques

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Research Status of Tissue Engineering of Endovascular Stent. and Spring Ring

Optical Properties of Aligned Zinc Oxide Nanorods

Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles

Review Report. Instrument & Apparatus 7 Organ function replacement device

Interpretation of Renal Transplant Biopsy. Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA

Supporting Information

Catheter and stent-based brachytherapy have shown promise

Recurrent lesions in AV access & Initial DCB experience in India

Supporting information. Thermosensitive Lipid Bilayer-Coated Mesoporous Carbon. Nanoparticles for Synergistic Thermochemotherapy of Tumor

Presents: Towards an implantable continuous glucose sensor. by Erik Johannessen. Illustration: Flemming Sveen

What is Nanotechnology?

The electrical properties of ZnO MSM Photodetector with Pt Contact Electrodes on PPC Plastic

Supporting Information for:

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

Lipoprotein Particle Profile

Gastric / EUS Metal Stents

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Roles of Flow Mechanics in Vascular Cell Biology in Health and Disease

Nanostructured ZnO as a solution-processable transparent electrode material for low-cost photovoltaics

Annals of RSCB Vol. XV, Issue 1

Fourth Practical Pathology. Circulatory disturbances

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER

Arteriosclerosis & Atherosclerosis

Supporting Information. Ligand-mediated Coating of Liposomes with Human Serum Albumin

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Bioabsorbable stents: early clinical results. Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

LIQUID JUNCTION PHOTOCELLS SYNTHESIZED WITH DYE COATED ZINC OXIDE FILMS. Department of Physics, University of Peradeniya, Peradeniya, Sri Lanka

Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Glutathione Reductase Assay Kit

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations

PRP Usage in Today's Implantology

EARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES

An Agent-Based Model of the Response to Angioplasty and Bare-Metal Stent Deployment in an Atherosclerotic Blood Vessel

CuraMedical. CuraMedical. Absorbable Haemostat Family. BCM proven performance in surgery

Biology of in-stent restenosis and rational for debulking

Magmaris: the impact of scaffold design and materials on reducing thrombogenicity

BIOCHEMISTRY OF BLOOD

History of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ

CHOUKROUN PRF SYSTEM

School of Pharmacy Faculty of Medicine The Chinese University of Hong Kong. Transdermal Drug Delivery System

Glass flow focusing microfluidic device for liposomes production

22 nd ETH-Conference on Combustion Generated Nanoparticles June 18 21, 2018; Zürich, Switzerland. Wolfgang G. Kreyling

Mechanical Calibration

BTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES

Chapter 19: Cardiovascular System: Blood

Transcription:

MULTILAYERED POLYELECTROLYTE FILMS CONTAINING IMMOBILIZED GOLD NANOPARTICLES Pallotta Arnaud

Gold nanoparticles Easily functionalized with drugs Increased payload Able to release drugs Chosen pharmaceutical effect Target 2

Gold nanoparticles Drawback: dissemination into the body Solutions Matrix Surface Immobilization Antibody labeling Implantable medical device 3

Film construction Polyelectrolyte film containing gold nanoparticles (AuNP) - Citrate stabilized AuNP - Prototype film Proof of concept - Glass deposited 1 cycle 3 cycles Implantable medical device polycation polyanio n Decher, Science (1997), 277, 1232-1237 4

Maximal wavelength absorption (a.u.) Film characterization 1 cycle 2 cycles 3 cycles 0,25 0,20 0,15 0,10 0,05 0,00 y = 0,0643x + 0,0029 R² = 0,9971 n=3 0 1 2 3 4 Cycle number Spectral properties maintained 5

Film characterization Dc = 5.2 ± 0.9 nm (n = 18) 3 cycles Density of AuNP deposited 8.1 ± 0.3 10 11 NP/cm² Dc = 5.3 ± 1.1 nm (n = 200) Thickness = 244 ± 31 nm Individualized AuNP into films Stability > 12 months (dry at 4 C or in physiological media at 37 C) Pallotta et al, Part. & Part. Sys. Char. (2017), 34, 1600184 6

Nanoparticles dissemination Stability under shear stress 96 h of physiological media: ph = 7.4 at 37 C Pressure: 1.5 bars Vacuum Flux medium Cf poster P4-7 Silicon seal Glass ware Film Gold quantification 7

Nanoparticles dissemination Film monitoring no significant modification Gold quantification from film no significant modification Gold quantification in medium below limit of detection < 0.2 µm Absence of AuNP leakage

Hémolysis (%) Film biocompatibility Hemolysis induced by films : * Whole blood rat 2 h, 37 C, agitation Centrifugation A haemoglobin 10 8 6 4 2 Biocompatibility assessed also using: - Protein adsorption - Capillary zone electrophoresis 0 Control - Control + Colloidal AuNP Film Contrôle - Contrôle + AuNP colloïdales Film Test : ANOVA 1 factor. Post test : Tukey-Kramer, n = 3 on 3 rats, mean ± standard deviation, * p<0,0001 vs ctrl + Pallotta et al, Part. & Part. Sys. Char. (2017), 34, 1600184 Film No significant hemolysis 9

Application Cardiovascular diseases vascular ischemia Erythrocyte Platelets Fibrin Media Intima Endothelial cells Lumen Lipidic cluster Smooth muscle cells Monocyte Macrophage LDL 10

Application Cardiovascular diseases vascular ischemia Treatment = angioplasty ± stent implantation Erythrocyte Platelets Fibrin Media Intima Endothelial cells Lumen Lipidic cluster Smooth muscle cells Monocyte Macrophage LDL 11

Application Cardiovascular diseases vascular ischemia Treatment = angioplasty ± stent implantation high risk of thrombosis and/or restenosis Multifactorial phenomenon Damaged endothelium Platelets activation/ agregation Protein deposition Smooth muscle cell proliferation /migration Erythrocyte Platelets Fibrin Media Intima Endothelial cells Lumen Lipidic cluster Smooth muscle cells Monocyte Macrophage LDL 12

Nitric oxide (NO) Application N O Damaged endothelium Platelets activation/ agregation Protein deposition Smooth muscle cell proliferation /migration Erythrocyte Platelets Fibrin Media Intima Endothelial cells Lumen Lipidic cluster Smooth muscle cells Monocyte Macrophage LDL 13

RSNO Application Drawback NO = short half-life NO storage : S-nitrosothiols (RSNO) biological storage form Gold nanoparticles (AuNP) functionalized with RSNO immobilization RSNO RSNO AuNP entrapped into polymeric films increased payload RSNO Controlled NO release 14

Application polymeric film Deposition on Nitinol stent (nickel-titane alloy) Gold dosage = 5 ± 3 x 10 12 AuNP/cm² 15

AuNP functionalization Stable plateform AuNP citrate DHLA GSH 7.5 ± 1.2 µmol GSH/ nmol AuNP High yield of NO grafting Luo et al, Col. Comm. (2016), 14, 8-12 16

Conclusion AuNP nanostructured films Biocompatible and stable: no AuNP dissemination Functionnalised AuNP with NO donors Wide range of materials Innovative therapeutic administration 17

Thank you for your attention! 18

Nanoparticles dissemination Film monitoring no significant modification Gold quantification from film no significant modification Gold quantification in medium below limit of detection < 0.2 µm T = 96 T = 0 Absence of AuNP leakage